RTOG1216: Randomized Phase II/III Trial of Adjuvant Radiation Therapy with Cisplatin, Docetaxel-Cetuximab, or Cisplatin-Atezolizumab in Pathologic High-Risk Squamous Cell Cancer of the Head and Neck
- Title
- Randomized Phase II/III Trial of Adjuvant Radiation Therapy with Cisplatin, Docetaxel-Cetuximab, or Cisplatin-Atezolizumab in Pathologic High-Risk Squamous Cell Cancer of the Head and Neck
- Principal Investigator
- Almubarak, Mohammed
- Phase
- II/III (Cancer Control)
- Age Group
- Adult
- Applicable Disease Sites
- Head and Neck Cancers
- Participating Institutions
- Camden Clark Medical Center
- Mary Babb Randolph Cancer Center
- Contacts
- Jeanne Fuscardo, RN, OCN
- Research Coordinator-WVUCI
- Phone: +1 304-243-3490
- Email: jeanne.fuscardo1@wvumedicine.org
- Nina Moore, RN
- Research Specialist
- Phone: +1 304-293-2991
- Email: nina.moore@hsc.wvu.edu
- Layla Tannoury
- Clinical Research Specialist
- Phone: +1 304-424-2585
- Email: layla.tannoury@wvumedicine.org